VTRS LAWSUIT ALERT: Levi & Korsinsky Notifies Viatris Inc. Investors – Lead Plaintiff Deadline June 3, 2025

NEW YORK, NY / ACCESS Newswire / June 1, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=151165&wire=1&utm_campaign=7 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call […]

Levi & Korsinsky Notifies Avis Budget Group, Inc. (CAR) Shareholders of Class Action Lawsuit and June 24, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / June 1, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=151164&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

July 21, 2025 Deadline Approaching: Join Class Action Against DoubleVerify Holdings, Inc. (DV) – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / June 1, 2025 / If you suffered a loss on your DoubleVerify Holdings, Inc. (NYSE:DV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/doubleverify-holdings-inc-lawsuit-submission-form-2?prid=151163&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Levi & Korsinsky Urges Bitfarms Ltd. (BITF) Shareholders to Act Before Lead Plaintiff Deadline July 8, 2025

NEW YORK, NY / ACCESS Newswire / June 1, 2025 / If you suffered a loss on your Bitfarms Ltd. (NASDAQ:BITF) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bitfarms-ltd-lawsuit-submission-form?prid=151166&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

ECG DEADLINE NOTICE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Everus Construction Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action – ECG

(NYSE:ECG), NEW YORK, June 01, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Everus Construction Group, Inc. (NYSE: ECG) between October 31, 2024 and February 11, 2025, both dates inclusive (the “Class Period”), including investors who held MDU Resources Group, Inc. (“MDU Resources”)

ECG DEADLINE NOTICE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Everus Construction Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action – ECG

ECG DEADLINE NOTICE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Everus Construction Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action – ECG GlobeNewswire June 01, 2025 NEW YORK, June 01, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor

Celestine Achi Launches Free AI Readiness Assessment Tool and Maturity Framework to Accelerate Africa’s AI Adoption in PR, Media, and Communications

As the AI revolution sweeps across industries worldwide, one African innovator is ensuring the continent doesn't just keep up – but leads. Dr. Celestine Achi, renowned AI educator, PR technology pioneer, and author of AI-Powered PR: The Essential Guide for Communications Leaders to Master Artificial Intelligence, has unveiled a groundbreaking AI Maturity Assessment Framework and

Recover Investment Losses: Levi & Korsinsky Files Class Action Against UroGen Pharma Ltd. (URGN)

NEW YORK, NY / ACCESS Newswire / June 1, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/urogen-pharma-ltd-lawsuit-submission-form?prid=151160&wire=1&utm_campaign=24 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Ongoing Investigation: Rocket Pharmaceuticals, Inc. (RCKT) May Have Misled Shareholders – Levi & Korsinsky Investigates

NEW YORK, NY / ACCESS Newswire / June 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Rocket Pharmaceuticals, Inc. ("Rocket Pharmaceuticals, Inc.") (NASDAQ:RCKT) concerning possible violations of federal securities laws. Rocket issued a press release on May 27, 2025, "announc[ing] an update related to RP-A501, its investigational gene

Scroll to Top